CONNECT WITH US:
linkedin [#161] Created with Sketch.
Explore our easy-to-use
Supplier Directory
Introducing the New Hosted Buyer Program at HIMSS24: An Exciting Opportunity for Executives in Healthcare IT
HIMSS and Health Connect Partners to Collaborate in 2024
Oct 16, 2023
IT conference collaboration

ORLANDO, FL – HIMSS Global Health Conference & Exhibition and Health Connect Partners are thrilled to announce the launch of a highly anticipated Hosted Buyer Program at the HIMSS24 event in Orlando. This innovative initiative is set to elevate the attendee and exhibitor experience to new heights, offering unparalleled opportunities for networking, collaboration, and business development within the dynamic healthcare technology sector.

HIMSS24, scheduled to take place March 11-15, in Orlando, is the most prestigious gathering in healthcare IT, attracting over 33,000 professionals and thought leaders from around the world who are creating tomorrow’s health. This year, the introduction of the Hosted Buyer Program aims to facilitate focused meetings between providers looking for solutions and the most innovative and trusted companies in healthcare IT.

The Hosted Buyer Program offers a unique platform for healthcare providers and other key decision-makers to connect with leading solution providers and technology innovators in a curated and productive environment. Participants in this program will benefit from:

Exclusive Matchmaking: HIMSS24 is partnering with Health Connect Partners to pair select buyers with exhibitors who align with their specific interests, ensuring the most productive conversations and meaningful interactions.

VIP Access: Hosted buyers will enjoy VIP treatment, including expedited registration, access to an exclusive Hosted Buyers area on the show floor with dedicated concierge services

Time Management: A series of focused, one-on-one meetings

Curated Exploration: By participating in pre-scheduled one-on-one meetings with top information and technology suppliers, hosted buyers can explore potential partnerships to improve patient experience, new technologies and more

"We are excited to introduce the Hosted Buyer Program at HIMSS24 in collaboration with Health Connect Partners, as it represents a significant leap forward in our efforts to connect executive buyers with the latest advancements in healthcare technology," said Elli Riley, Vice President, HIMSS Global Health Conference & Exhibition. "This program is designed to foster collaboration, connection, and business growth at HIMSS24."

David Mason, Founder and CEO of Health Connect Partners added, “We are pleased to partner with HIMSS Global Health Conference & Exhibition to manage the Hosted Buyer program. We have been conducting Hosted Buyer events since our inception in 2006 and have served the Hospital IT market since 2011.  This is a great partnership, and we look forward to adding value to the already successful HIMSS Global event starting in March of 2024.”

Applications for the Hosted Buyer Program at HIMSS24 are now open. Apply for the program as part of your event registration. Interested healthcare professionals are encouraged to register and apply early to secure their spot in this exclusive program.

HIMSS24 exhibitors interested in participating in the Hosted Buyer Program should contact their account manager or email salesinfo@himss.org

Learn more about HIMSS24. Join the conversation on Twitter and LinkedIn with #HIMSS24 or by following @HIMSS. 

About HIMSS

Vision

To realize the full health potential of every human, everywhere.

Mission

Reform the global health ecosystem through the power of information and technology.

HIMSS (Healthcare Information and Management Systems Society) is a global advisor, thought leader and member-based society committed to reforming the global health ecosystem through the power of information and technology. As a mission-driven nonprofit, HIMSS offers a unique depth and breadth of expertise in health innovation, public policy, workforce development, research and digital health transformation to advise leaders, stakeholders and influencers across the global health ecosystem on best practices. With a community-centric approach, our innovation engine delivers key insights, education and engaging events to healthcare providers, payers, governments, startups, life sciences and other health services organizations, ensuring they have the right information at the point of decision.

HIMSS has served the global health community for more than 60 years, with focused operations across North America, Europe, the United Kingdom, the Middle East and Asia-Pacific. Our members include more than 120,000 individuals, 440 provider organizations, 510 nonprofit partners and 560 health services organizations. HIMSS offers a variety of membership types and ways to get involved.

About Health Connect Partners

Health Connect Partners (HCP) is a healthcare education firm focused on bringing the very best in education to healthcare providers and their suppliers. Each conference features their signature Reverse Expo sessions, one-on-one hosted buyer meetings. HCP’s goal is to connect providers and suppliers through industry-specific conferences, which currently include Hospital Pharmacy, O.R. & Surgical, Radiology & Imaging, Hospital Supply Chain, and Nursing Home, in addition to the partnership with HIMSS. For conference dates and more information, visit www.HLTHCP.com.

About Informa Markets

Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. We provide marketplace participants around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, targeted digital services and actionable data solutions. We connect buyers and sellers across more than a dozen global verticals, including Boating, Pharmaceuticals, Food, Fashion, and Infrastructure. As the world's leading market-making company, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit informamarkets.com.

Latest Industry news
View all Industry News
Bayer Logo
AskBio Earns FDA Rare Pediatric & Orphan Drug Status for AB-1003 in Limb-Girdle Muscular Dystrophy
Nov 07, 2024

Research Triangle Park, N.C.  – Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that AB-1003 (also known as LION-101) has received rare pediatric disease designation and orphan-drug designation from the US Food and Drug Administration (FDA) for the treatment of limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9).

hotomicrograph of bone marrow aspirate showing myeloblasts of acute myeloid leukemia (AML), a cancer of white blood cells.
FDA grants accelerated approval to asciminib for newly diagnosed chronic myeloid leukemia
Nov 01, 2024

The Food and Drug Administration granted accelerated approval to asciminib (Scemblix, Novartis AG) for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP).

White oxy pills
Protega Pharmaceuticals Gains FDA Approval for Abuse-Deterrent ROXYBOND™ 10 mg Pain Tablet
Oct 29, 2024

PRINCETON, N.J - Protega Pharmaceuticals Inc. recently announced that the U.S. Food and Drug Administration (FDA) has approved ROXYBOND™ (oxycodone hydrochloride) immediate-release (IR) CII 10 mg tablet for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. ROXYBOND is the first and only FDA-approved abuse-deterrent IR 10 mg oxycodone formulation that is expected to reduce abuse by intranasal and intravenous routes.